Charnwood Molecular at Mastering Medicinal Chemistry, Boston - 16-17 June 2016

LOUGHBOROUGH, U.K. - June 14, 2016 - PRLog -- Charnwood Molecular Ltd is a leading UK-based CRO providing Drug Discovery and early Development services to a wide range of international clients. Founded in 1998, we now support the drug discovery activities of a variety of organisations from virtual startups to large Pharmaceutical companies. We offer a flexible service from single-compound synthesis to full  management of Medicinal Chemistry projects.

The company's Business Development Director, Dr Robin Wilkes, will be at the event and should you wish to organise to meet up with him, please email him directly at:

mailto: r.wilkes@charnwood-molecular.com

The Mastering Medicinal Chemistry conference is now in its 14th year and remains a well-established and popular annual event for senior-level medicinal chemists. The 2016 program features the hottest topics in medicinal chemistry from leaders in the pharmaceutical, biotech and academic spaces. Through cutting-edge case studies, panel discussions, poster presentations and breakout discussions, we showcase the biggest opportunities for small molecules. Several topics will be given special coverage, including small molecules in immuno-oncology, covalent inhibitors, receptor kinetics, CNS kinases, macrocycles, screening diversity, high-throughput experimentation, and novel targets such as RNA, and transporters.


http://www.charnwood-molecular.com